
Regulatory milestone affirms GSK’s strong commitment and scientific capabilities to fighting infectious diseases LONDON/GENEVA, 29-Nov-2017 — /EuropaWire/ — GSK and Medicines for Malaria Venture (MMV) today announced the submission of a new drug application (NDA) by GSK to the United States … Read the full press release